132 related articles for article (PubMed ID: 37203753)
1. First Steps Towards a Risk of Bias Corpus of Randomized Controlled Trials.
Dhrangadhariya A; Hilfiker R; Sattelmayer M; Giacomino K; Caliesch R; Elsig S; Naderi N; Müller H
Stud Health Technol Inform; 2023 May; 302():586-590. PubMed ID: 37203753
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Risk of bias judgments for random sequence generation in Cochrane systematic reviews were frequently not in line with Cochrane Handbook.
Barcot O; Boric M; Poklepovic Pericic T; Cavar M; Dosenovic S; Vuka I; Puljak L
BMC Med Res Methodol; 2019 Aug; 19(1):170. PubMed ID: 31382898
[TBL] [Abstract][Full Text] [Related]
4. Adequacy of risk of bias assessment in surgical vs non-surgical trials in Cochrane reviews: a methodological study.
Barcot O; Boric M; Dosenovic S; Cavar M; Jelicic Kadic A; Poklepovic Pericic T; Vukicevic I; Vuka I; Puljak L
BMC Med Res Methodol; 2020 Sep; 20(1):240. PubMed ID: 32993499
[TBL] [Abstract][Full Text] [Related]
5. Inter-review agreement of risk-of-bias judgments varied in Cochrane reviews.
Könsgen N; Barcot O; Heß S; Puljak L; Goossen K; Rombey T; Pieper D
J Clin Epidemiol; 2020 Apr; 120():25-32. PubMed ID: 31866473
[TBL] [Abstract][Full Text] [Related]
6. The judgement of biases included in the category "other bias" in Cochrane systematic reviews of interventions: a systematic survey.
Babic A; Pijuk A; Brázdilová L; Georgieva Y; Raposo Pereira MA; Poklepovic Pericic T; Puljak L
BMC Med Res Methodol; 2019 Apr; 19(1):77. PubMed ID: 30971219
[TBL] [Abstract][Full Text] [Related]
7. The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application.
Minozzi S; Cinquini M; Gianola S; Gonzalez-Lorenzo M; Banzi R
J Clin Epidemiol; 2020 Oct; 126():37-44. PubMed ID: 32562833
[TBL] [Abstract][Full Text] [Related]
8. Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews.
Yao Y; Shen J; Luo J; Li N; Liao X; Zhang Y
Trials; 2024 Jun; 25(1):405. PubMed ID: 38907276
[TBL] [Abstract][Full Text] [Related]
9. Frequency of use and adequacy of Cochrane risk of bias tool 2 in non-Cochrane systematic reviews published in 2020: Meta-research study.
Babić A; Barcot O; Visković T; Šarić F; Kirkovski A; Barun I; Križanac Z; Ananda RA; Fuentes Barreiro YV; Malih N; Dimcea DA; Ordulj J; Weerasekara I; Spezia M; Žuljević MF; Šuto J; Tancredi L; Pijuk A; Sammali S; Iascone V; von Groote T; Poklepović Peričić T; Puljak L
Res Synth Methods; 2024 May; 15(3):430-440. PubMed ID: 38262609
[TBL] [Abstract][Full Text] [Related]
10. Poor reliability between Cochrane reviewers and blinded external reviewers when applying the Cochrane risk of bias tool in physical therapy trials.
Armijo-Olivo S; Ospina M; da Costa BR; Egger M; Saltaji H; Fuentes J; Ha C; Cummings GG
PLoS One; 2014; 9(5):e96920. PubMed ID: 24824199
[TBL] [Abstract][Full Text] [Related]
11. Risk of Bias in Iranian Randomized Trials Included in Cochrane Reviews.
Kabir A; Sofi-Mahmudi A; Karimi Behnagh A; Eidkhani V; Baradaran HR; Kabiri P; Haghdoost A; Mesgarpour B
Arch Iran Med; 2022 Jun; 25(6):375-382. PubMed ID: 35943017
[TBL] [Abstract][Full Text] [Related]
12. Risk of bias assessments and reporting quality of systematic reviews and randomized controlled trials examining acupuncture for depression: An overview and meta-epidemiology study.
Luo S; Long Y; Xiao W; Wang X; Chen R; Guo Q; Liu J; Shao R; Du L; Chen M
J Evid Based Med; 2020 Feb; 13(1):25-33. PubMed ID: 32112515
[TBL] [Abstract][Full Text] [Related]
13. SYRCLE's risk of bias tool for animal studies.
Hooijmans CR; Rovers MM; de Vries RB; Leenaars M; Ritskes-Hoitinga M; Langendam MW
BMC Med Res Methodol; 2014 Mar; 14():43. PubMed ID: 24667063
[TBL] [Abstract][Full Text] [Related]
14. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
15. Risk of bias assessments for selective reporting were inadequate in the majority of Cochrane reviews.
Saric F; Barcot O; Puljak L
J Clin Epidemiol; 2019 Aug; 112():53-58. PubMed ID: 31009658
[TBL] [Abstract][Full Text] [Related]
16. Risk of bias of randomized trials over time.
Reveiz L; Chapman E; Asial S; Munoz S; Bonfill X; Alonso-Coello P
J Clin Epidemiol; 2015 Sep; 68(9):1036-45. PubMed ID: 26227423
[TBL] [Abstract][Full Text] [Related]
17. The effect of the CONSORT statement on the amount of "unclear" Risk of Bias reporting in Cochrane Systematic Reviews.
Rademaker MM; Ramakers GGJ; Smit AL; Hooft L; Stegeman I
PLoS One; 2020; 15(7):e0235535. PubMed ID: 32650340
[TBL] [Abstract][Full Text] [Related]
18. Usability and sensitivity of the risk of bias assessment tool for randomized controlled trials of pharmacist interventions.
Tonin FS; Lopes LA; Rotta I; Bonetti AF; Pontarolo R; Correr CJ; Fernandez-Llimos F
Int J Clin Pharm; 2019 Jun; 41(3):785-792. PubMed ID: 30963446
[TBL] [Abstract][Full Text] [Related]
19. Risk of bias over time in updates of Cochrane oral health reviews.
Faggion CM; Aranda L; Pandis N; Alarcón MA; Diaz KT
J Dent; 2019 Jan; 80():63-68. PubMed ID: 30342067
[TBL] [Abstract][Full Text] [Related]
20. Cochrane risk of bias tool was used inadequately in the majority of non-Cochrane systematic reviews.
Puljak L; Ramic I; Arriola Naharro C; Brezova J; Lin YC; Surdila AA; Tomajkova E; Farias Medeiros I; Nikolovska M; Poklepovic Pericic T; Barcot O; Suarez Salvado M
J Clin Epidemiol; 2020 Jul; 123():114-119. PubMed ID: 32247026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
